"It is our clear expectation that, according to the latest surveys
by the European Medicines Agency, the vaccines will receive
marketing authorisation in Europe early next year," Klaus Cichutek,
head of the Paul Ehrlich Institute, told a virtual press briefing on
Friday.
(Reporting by Caroline Copley; editing by Thomas Seythal)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |